In terms of M&A activity, 2022 is a rather quiet year so far compared to record-breaking year 2021 when private equity investments boomed. In this article, read about recent trends and an outlook on M&A deals in the life science industry. Upswing in biopharma M&As in Q2 2022 According to a report by J.P. Morgan, … Continue reading Current Trends in M&A Activity
Category: Publications & News
In this chapter we publish articles about Biotechgate as well as Biotech related topics. Also most of the articles published in newsletters are available here.
Strong Partnership with Maryland Department of Commerce: Interview with Ulyana Desiderio
Biotechgate is in close partnership with the Maryland Department of Commerce. In an interview with Ulyana Desiderio, the Director of the Department’s Office of Life Science, she tells Biotechgate about her experience with the partnership and her work in the state’s life science ecosystem. Ulyana Desiderio is Director of the Office of Life Science at … Continue reading Strong Partnership with Maryland Department of Commerce: Interview with Ulyana Desiderio
The Current State of Therapeutics Financing: Trends in Public Market
Last month’s article on private equity therapeutics financing trends showed how biotech start-ups struggle to raise private equity investment this year, following the pandemic-driven life sciences boom. In this article, we will take a closer look at how recent challenges are reflected in the IPO market and outline public financing trends. In the wake of … Continue reading The Current State of Therapeutics Financing: Trends in Public Market
Finding Financial Information in Biotechgate
With over 1.3 million total entries, the Biotechgate Business Development and Investor databases serve as your primary source of information relating to the life science industry. This allows you to have access to data on organizations from start-ups right through to well-established multinationals and everything in between. Read on for an overview of the financial … Continue reading Finding Financial Information in Biotechgate
The 10 Largest Life Science IPOs (January – July, 2022)
IPOs serve as the lifeblood of the life science industry, allowing companies access to a vast source of capital that can fund their R&D activities and give previous investors a return on their initial financing. In 2022, there has been a noted contraction in the performance of life science IPOs which, in turn, has caused … Continue reading The 10 Largest Life Science IPOs (January – July, 2022)
The Current State of Therapeutics Financing: Trends in Private Equity Investment
The global pandemic generated record investments in life science companies back in 2020 and 2021, when growth was largely driven by development of COVID-19 vaccines and drugs that helped overcome the acute phase of the pandemic. However, in 2022 the war in Ukraine has led to macroeconomic changes that causes the financial environment for the … Continue reading The Current State of Therapeutics Financing: Trends in Private Equity Investment
Oncology Trends: The Story So Far
Oncology has cemented itself as one of the leading therapeutic areas within the biopharma space, with various innovations and changes constantly being introduced in an effort to curb the number of cancer cases and reduce mortality rates. Find some of the key trends that are currently happening within the oncology landscape in this article, including … Continue reading Oncology Trends: The Story So Far
The Role of Artificial Intelligence in the Biopharma Industry
Artificial intelligence (AI) has found itself being utilized with increased frequency within the biopharma industry, with companies often collaborating with AI platform providers for a myriad of reasons and mutual benefits. In this article, find out about the growing role that AI is currently playing within a sector that is constantly evolving. Searching for Drug … Continue reading The Role of Artificial Intelligence in the Biopharma Industry
Why Data is Important for Pharma and Biotechs
Data is a commodity across all life science companies, serving to help drive an organization’s strategic direction and helping to understand what has and has not worked in the past. With the increased emphasis being focused on the variety of uses of data in the day-to-day business operations, here are some reasons why it can … Continue reading Why Data is Important for Pharma and Biotechs
Protecting Your Intellectual Property as a Start-up
Bringing a product to the market is known to be a long journey for life sciences start-ups. It all starts with protecting the underlying ideas and thoughts: the intellectual property (IP). But when is the right time to file a patent application, and at what stage of the process should you think about strategic partnerships … Continue reading Protecting Your Intellectual Property as a Start-up